Your search returned 3 results.

Results
	1.	Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström's macroglobulinemia. [electronic resource] by Herth, Isabelle Hensel, Manfred Rieger, Michael Horstmann, Kristin Hiddemann, Wolfgang Dreyling, Martin Koniczek, Silvia Witzens-Harig, Mathias Ho, Anthony D Producer: 20151007 In: Leukemia & lymphoma vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma. [electronic resource] by Neuber, Brigitte Herth, Isabelle Tolliver, Claudia Schoenland, Stefan Hegenbart, Ute Hose, Dirk Witzens-Harig, Mathias Ho, Anthony D Goldschmidt, Hartmut Klein, Bernard Hundemer, Michael Producer: 20110923 In: Journal of immunology (Baltimore, Md. : 1950) vol. 187 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma. [electronic resource] by Herth, Isabelle Witzens-Harig, Mathias Beckhove, Philipp Hose, Dirk Meissner, Tobias Neuber, Brigitte Engelhardt, Melanie Haas, Jürgen Neben, Kai Ho, Anthony D Klein, Bernard Goldschmidt, Hartmut Hundemer, Michael Producer: 20130520 In: Experimental hematology vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)